T2000 in Essential Tremor - Open Label Continuation

Summary

This study will evaluate the safety and efficacy of T2000 when used to treat patients with moderate to severe essential tremor over an 18 month period.

Timeline

Start

2007-08

Primary completion

2009-11

Completion

2009-12

Publications

• Background Melmed C, Moros D, Rutman H. Treatment of essential tremor with the barbiturate T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid). Mov Disord. 2007 Apr 15;22(5):723-7. doi: 10.1002/mds.21321.

Drugs

Indications